Found: 45
Select item for more details and to access through your institution.
Tumor Response Predicts Survival Time of Nivolumab Monotherapy for Advanced Gastric Cancer: A Subgroup Analysis of the DELIVER Trial (JACCRO GC-08).
- Published in:
- Oncologist, 2024, v. 29, n. 8, p. e997, doi. 10.1093/oncolo/oyae056
- By:
- Publication type:
- Article
Clinical features associated with NeoRAS wild-type metastatic colorectal cancer A SCRUM-Japan GOZILA substudy.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-50026-4
- By:
- Publication type:
- Article
False-positive [<sup>18</sup>F]FAPI-74 uptake caused by blood retention due to external jugular vein thrombus: Pitfall in the early-phase scan.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 6, p. 1790, doi. 10.1007/s00259-024-06598-w
- By:
- Publication type:
- Article
A Phase II Study of FOLFIRI Plus Ziv-Aflibercept After Trifluridine/Tipiracil Plus Bevacizumab in Patients with Metastatic Colorectal Cancer: WJOG 11018G.
- Published in:
- Targeted Oncology, 2024, v. 19, n. 2, p. 181, doi. 10.1007/s11523-024-01043-2
- By:
- Publication type:
- Article
Trastuzumab deruxtecan in patients with locally advanced or metastatic HER2-positive gastric cancer: a multicenter, open-label, expanded-access study.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 1, p. 27, doi. 10.1007/s10147-023-02422-x
- By:
- Publication type:
- Article
Role of plasma angiogenesis factors in the efficacy of first‐line chemotherapy combined with biologics in RAS wild‐type metastatic colorectal cancer: Results from the GI‐SCREEN CRC‐Ukit study.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 18, p. 18702, doi. 10.1002/cam4.6486
- By:
- Publication type:
- Article
Phase II clinical trial to study the safety and efficacy of combined S-1 + oxaliplatin therapy as neoadjuvant chemotherapy for locally advanced gastric cancer in older patients.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 9, p. 1166, doi. 10.1007/s10147-023-02373-3
- By:
- Publication type:
- Article
Author Correction: Regorafenib is suitable for advanced colorectal cancer patients who have previously received trifluridine/tipiracil plus bevacizumab.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Nivolumab versus irinotecan as third- or later-line treatment for advanced gastric cancer: a multi-center retrospective study.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 6, p. 756, doi. 10.1007/s10147-023-02330-0
- By:
- Publication type:
- Article
Regorafenib is suitable for advanced colorectal cancer patients who have previously received trifluridine/tipiracil plus bevacizumab.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-29706-6
- By:
- Publication type:
- Article
Real-World Data of Trifluridine/Tipiracil for Patients With Advanced Gastric Cancer: A Multi-Institutional Retrospective Study.
- Published in:
- Clinical Medicine Insights: Oncology, 2022, p. 1, doi. 10.1177/11795549221137135
- By:
- Publication type:
- Article
Improvement of Body Weight and Nutritional Status in Gastric Cancer Patients Enhances the Benefit of Nivolumab Therapy.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 20, p. 6100, doi. 10.3390/jcm11206100
- By:
- Publication type:
- Article
Fecal microbiota in patients with a stoma decreases anaerobic bacteria and alters taxonomic and functional diversities.
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2022, v. 12, p. 01, doi. 10.3389/fcimb.2022.925444
- By:
- Publication type:
- Article
Primary tumor location as a predictor of survival in patients with RAS wild-type colorectal cancer who receive molecularly targeted drugs as first-line therapy: a multicenter real-world observational study by the Japanese Society for Cancer of the Colon and Rectum
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 9, p. 1450, doi. 10.1007/s10147-022-02208-7
- By:
- Publication type:
- Article
Phase IIb study of pembrolizumab combined with S‐1 + oxaliplatin or S‐1 + cisplatin as first‐line chemotherapy for gastric cancer.
- Published in:
- Cancer Science, 2022, v. 113, n. 8, p. 2814, doi. 10.1111/cas.15462
- By:
- Publication type:
- Article
Real-world effectiveness of third- or later-line treatment in Japanese patients with HER2-positive, unresectable, recurrent or metastatic gastric cancer: a retrospective observational study.
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 7, p. 1154, doi. 10.1007/s10147-022-02162-4
- By:
- Publication type:
- Article
Real-World Data of Trastuzumab Deruxtecan for Advanced Gastric Cancer: A Multi-Institutional Retrospective Study.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 8, p. 2247, doi. 10.3390/jcm11082247
- By:
- Publication type:
- Article
Real-world effectiveness of nivolumab in advanced gastric cancer: the DELIVER trial (JACCRO GC-08).
- Published in:
- Gastric Cancer, 2022, v. 25, n. 1, p. 235, doi. 10.1007/s10120-021-01237-x
- By:
- Publication type:
- Article
Direct Oral Anticoagulants for the Treatment of Venous Thromboembolism in Patients With Active Cancer.
- Published in:
- In Vivo, 2021, v. 35, n. 5, p. 2747, doi. 10.21873/invivo.12559
- By:
- Publication type:
- Article
Associated characteristics and treatment outcomes of medication-related osteonecrosis of the jaw in patients receiving denosumab or zoledronic acid for bone metastases.
- Published in:
- Supportive Care in Cancer, 2021, v. 29, n. 8, p. 4763, doi. 10.1007/s00520-021-06018-x
- By:
- Publication type:
- Article
Hepatectomy Followed by Adjuvant Chemotherapy with 3‐Month Capecitabine Plus Oxaliplatin for Colorectal Cancer Liver Metastases.
- Published in:
- Oncologist, 2021, v. 26, n. 7, p. e1125, doi. 10.1002/onco.13816
- By:
- Publication type:
- Article
Clinical and prognostic features of patients with detailed RAS/BRAF-mutant colorectal cancer in Japan.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Phase 1 study of Gemcitabine/Nab-paclitaxel/S-1 in patients with unresectable pancreatic cancer (GeNeS1S trial).
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 87, n. 1, p. 65, doi. 10.1007/s00280-020-04174-1
- By:
- Publication type:
- Article
Phase Ib/II Study of Biweekly TAS‐102 in Combination with Bevacizumab for Patients with Metastatic Colorectal Cancer Refractory to Standard Therapies (BiTS Study).
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. e1855, doi. 10.1634/theoncologist.2020-0643
- By:
- Publication type:
- Article
Phase Ib study of FOLFOXIRI plus ramucirumab as first-line treatment for patients with metastatic colorectal cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Regorafenib vs trifluridine/tipiracil for metastatic colorectal cancer refractory to standard chemotherapies: A multicenter retrospective comparison study in Japan.
- Published in:
- PLoS ONE, 2020, v. 15, n. 6, p. 1, doi. 10.1371/journal.pone.0234314
- By:
- Publication type:
- Article
A simplified method for therapeutic drug monitoring of mitotane by gas chromatography‐electron ionization‐mass spectrometry.
- Published in:
- Biomedical Chromatography, 2020, v. 34, n. 3, p. 1, doi. 10.1002/bmc.4776
- By:
- Publication type:
- Article
Sex differences in the safety of S‐1 plus oxaliplatin and S‐1 plus cisplatin for patients with metastatic gastric cancer.
- Published in:
- Cancer Science, 2019, v. 110, n. 9, p. 2875, doi. 10.1111/cas.14117
- By:
- Publication type:
- Article
Evaluation of health-related quality of life via the Computer-Based Health Evaluation System (CHES) for Japanese metastatic breast cancer patients: a single-center pilot study.
- Published in:
- Breast Cancer (13406868), 2019, v. 26, n. 2, p. 255, doi. 10.1007/s12282-018-0905-1
- By:
- Publication type:
- Article
Prevalence and risk factors of hepatitis B virus reactivation in patients with solid tumors with resolved HBV infection.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2019, v. 15, n. 1, p. 63, doi. 10.1111/ajco.13050
- By:
- Publication type:
- Article
Early tumor shrinkage and depth of response in patients with advanced gastric cancer: a retrospective analysis of a randomized phase III study of first-line S-1 plus oxaliplatin vs. S-1 plus cisplatin.
- Published in:
- Gastric Cancer, 2019, v. 22, n. 1, p. 138, doi. 10.1007/s10120-018-0845-7
- By:
- Publication type:
- Article
Phase Ib study of irinotecan and ramucirumab for advanced gastric cancer previously treated with fluoropyrimidine with/without platinum and taxane.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Acute Liver Failure with Diffuse Liver Metastasis from Breast Cancer, Not Detected by Computed Tomography: 2 Case Reports.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Phase I study of primary treatment with 5-FU, oxaliplatin, irinotecan, levofolinate, and panitumumab combination chemotherapy in patients with advanced/recurrent colorectal cancer involving the wild-type <italic>RAS</italic> gene: the JACCRO CC-14 study.
- Published in:
- International Journal of Clinical Oncology, 2018, v. 23, n. 3, p. 490, doi. 10.1007/s10147-017-1228-5
- By:
- Publication type:
- Article
A Prospective, Multicenter Phase II Study of the Efficacy and Feasibility of 15-minute Panitumumab Infusion Plus Irinotecan for Oxaliplatin- and Irinotecan-refractory, KRAS Wild-type Metastatic Colorectal Cancer (Short Infusion of Panitumumab Trial).
- Published in:
- 2018
- By:
- Publication type:
- journal article
First-line chemotherapy with capecitabine/oxaliplatin for advanced gastric cancer: A phase I study.
- Published in:
- Molecular & Clinical Oncology, 2017, v. 7, n. 3, p. 347, doi. 10.3892/mco.2017.1335
- By:
- Publication type:
- Article
Impact of progression type on overall survival in patients with advanced gastric cancer based on randomized phase III study of S-1 plus oxaliplatin versus S-1 plus cisplatin.
- Published in:
- Gastric Cancer, 2017, v. 20, n. 4, p. 640, doi. 10.1007/s10120-016-0666-5
- By:
- Publication type:
- Article
Meta-analysis supporting noninferiority of oxaliplatin plus S-1 to cisplatin plus S-1 in first-line treatment of advanced gastric cancer (G-SOX study): indirect comparison with S-1 alone.
- Published in:
- International Journal of Clinical Oncology, 2016, v. 21, n. 4, p. 668, doi. 10.1007/s10147-015-0938-9
- By:
- Publication type:
- Article
Efficacy and safety of S-1 and oxaliplatin combination therapy in elderly patients with advanced gastric cancer.
- Published in:
- Gastric Cancer, 2016, v. 19, n. 3, p. 919, doi. 10.1007/s10120-015-0549-1
- By:
- Publication type:
- Article
S-1 and irinotecan with or without bevacizumab versus 5-fluorouracil and leucovorin plus oxaliplatin with or without bevacizumab in metastatic colorectal cancer: a pooled analysis of four phase II studies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 3, p. 605, doi. 10.1007/s00280-015-2834-4
- By:
- Publication type:
- Article
Multicenter phase II study of FOLFIRI plus bevacizumab after discontinuation of oxaliplatin-based regimen for advanced or recurrent colorectal cancer (CR0802).
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1175-3
- By:
- Publication type:
- Article
Multicenter phase II study of FOLFIRI plus bevacizumab after discontinuation of oxaliplatin-based regimen for advanced or recurrent colorectal cancer (CR0802).
- Published in:
- 2015
- By:
- Publication type:
- journal article
A Phase II Clinical Study of mFOLFOX6 Plus Bevacizumab as First-line Therapy for Japanese Advanced/Recurrent Colorectal Cancer Patients.
- Published in:
- Japanese Journal of Clinical Oncology, 2013, v. 43, n. 11, p. 1080, doi. 10.1093/jjco/hyt127
- By:
- Publication type:
- Article
A phase I escalating single-dose and weekly fixed-dose study of cetuximab pharmacokinetics in Japanese patients with solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 3, p. 557, doi. 10.1007/s00280-008-0904-6
- By:
- Publication type:
- Article
Phase I study of irinotecan and S-1 combination therapy in patients with metastatic gastric cancer.
- Published in:
- International Journal of Clinical Oncology, 2003, v. 8, n. 6, p. 374, doi. 10.1007/s10147-003-0359-z
- By:
- Publication type:
- Article